Instrument | Purpose | N studies | Population / setting | Countries in which the studies were conducted | Internal consistency (alpha) | Test-retest reliability | Factor structure | Mean score difference with paper version | Convergent validity | Criterion validity (AUC) |
---|---|---|---|---|---|---|---|---|---|---|
Anxiety | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
BAI | Symptom severity | 3 | G1, P3 | SE | .88–.89 (2) |  | 4 factors (1) | None, lower (2) |  |  |
Depression and anxiety | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
CIDI-SF | Diagnosis & screening | 1 | G1 | SE | Â | Â | Â | Â | Â | (1) |
DASS | Symptom severity | 1 | G5 | US | .93–.95 (1) | (1) |  |  | (1) |  |
HADS | Screening & symptom severity | 5 | G1, G5, P5, P7 | NZ, SE, UK | .76–.88 (5) | (1) | 3 factors (2) | None (2) | (1) |  |
SQ-48 | Screening & symptom severity | 1 | G1, P1 | NL | .84–.93 (1) |  | 9 factors (1) |  | (1) | .75–.91 (1) |
WB-DAT | Screening | 1 | P8 | CA | Â | Â | Â | Â | Â | (1) |
WSQ | Screening | 1 | G1 | NL |  |  |  |  |  | .65–.81 (1) |
Depression and anxiety (postpartum) | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
PDM | Screening | 1 | G1 | US | .84–.88 (1) |  | 2 factors (1) |  | (1) |  |